Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ziftomenib (KO-539) is an inhibitor of menin-MLL interaction with antitumor activity and can be used to study leukemia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 318.00 | |
5 mg | In stock | $ 762.00 | |
10 mg | In stock | $ 1,060.00 | |
25 mg | In stock | $ 1,490.00 | |
50 mg | In stock | $ 1,990.00 | |
100 mg | In stock | $ 2,480.00 |
Description | Ziftomenib (KO-539) is an inhibitor of menin-MLL interaction with antitumor activity and can be used to study leukemia. |
In vitro | Zifomenib acts highly selective in MLL-r and NPM1mut acute myeloid leukemia and synergizes with a variety of targeted drugs in vitro[1]. |
Synonyms | KO-539 |
Molecular Weight | 717.871 |
Formula | C33H42F3N9O2S2 |
CAS No. | 2134675-36-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 80 mg/mL (111.44 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ziftomenib 2134675-36-6 Chromatin/Epigenetic Histone Methyltransferase KO 539 KO539 KO-539 inhibitor inhibit